FilingIndex
← The Wire
CHRSNasdaq

Coherus Oncology, Inc.

Biological Products, (No Diagnostic Substances) · DE · CIK 1512762

Develops and commercializes innovative immuno-oncology medicines, including LOQTORZI, for various cancers

red 8-K · 90d
$216M
Market cap
$1.45
Last close
-3.3%
1D
-2.0%
5D
1.1M
Volume
Price · last 39 sessions-16.2%
May 4L $1.36 · H $1.95Jun 29
335
Total filings
Jun 15, 2026
Last filing
12/31
Fiscal year end
8-KAuditor ChangeJun 15, 20268-KShareholder VoteJun 1, 2026DEFA14ADEFA14AMay 28, 202610-Q10-QMay 11, 20268-KResults of OperationsMay 11, 2026DEFA14ADEFA14AMay 5, 2026DEF 14ADEF 14AApr 20, 2026DEFA14ADEFA14AApr 14, 202610-K10-KMar 9, 20268-KResults of OperationsMar 9, 20268-KCompany UpdateFeb 17, 2026424B5424B5Feb 13, 2026424B5424B5Feb 12, 20268-KCompany UpdateFeb 4, 20268-KCompany UpdateJan 23, 2026424B5424B5Jan 23, 20268-KResults of OperationsJan 13, 20268-KCompany UpdateNov 13, 202510-Q10-QNov 6, 20258-KResults of OperationsNov 6, 20258-KCompany UpdateSep 8, 202510-Q10-QAug 7, 20258-KResults of OperationsAug 7, 20258-KDelisting NoticeJul 3, 20258-KShareholder VoteJun 13, 20258-KBylaw Amendment · Reg FD DisclosureMay 30, 202510-Q10-QMay 12, 20258-KResults of OperationsMay 12, 2025DEFA14ADEFA14AApr 29, 2025DEF 14ADEF 14AApr 29, 20258-KExecutive ChangeApr 25, 20258-KExecutive ChangeApr 22, 20258-KAcquisition / Disposition · Reg FD DisclosureApr 14, 20258-KMaterial Agreement · Company UpdateApr 1, 202510-K10-KMar 17, 20258-KShareholder VoteMar 13, 20258-KResults of OperationsMar 10, 2025DEFA14ADEFA14AMar 4, 20258-KCompany UpdateMar 4, 2025DEFA14ADEFA14AJan 30, 2025DEFA14ADEFA14AJan 14, 20258-KResults of Operations · Reg FD DisclosureJan 13, 20258-KExecutive ChangeDec 4, 2024DEFA14ADEFA14ADec 4, 2024DEFA14ADEFA14ADec 4, 2024DEFA14ADEFA14ADec 3, 2024DEFA14ADEFA14ADec 3, 20248-KMaterial Agreement · Reg FD DisclosureDec 3, 2024SC 13GSC 13GNov 13, 202410-Q10-QNov 6, 20248-KResults of OperationsNov 6, 20248-KReg FD DisclosureSep 13, 202410-Q10-QAug 8, 20248-KExecutive Change · Results of OperationsAug 8, 20248-KMaterial AgreementJul 2, 20248-KMaterial Agreement · Acquisition / DispositionJun 27, 20248-KExecutive ChangeJun 5, 20248-KShareholder VoteJun 4, 20248-K/ACompany UpdateMay 21, 2024DEFA14ADEFA14AMay 13, 202410-Q10-QMay 9, 20248-KResults of OperationsMay 9, 20248-KMaterial Agreement · Agreement TerminatedMay 9, 2024DEFA14ADEFA14AApr 15, 2024DEF 14ADEF 14AApr 15, 202410-K10-KMar 15, 20248-KResults of OperationsMar 13, 20248-KDebt Acceleration · Acquisition / DispositionMar 4, 20248-KExecutive ChangeFeb 22, 20248-KMaterial Agreement · Reg FD DisclosureFeb 5, 20248-KMaterial Agreement · Reg FD DisclosureJan 22, 20248-KResults of OperationsJan 10, 20248-KCompany UpdateJan 10, 20248-KCompany UpdateDec 27, 20238-KExecutive ChangeDec 11, 20238-KExecutive ChangeDec 7, 20238-KReg FD DisclosureNov 27, 20238-K/ACompany UpdateNov 13, 202310-Q10-QNov 6, 20238-KResults of OperationsNov 6, 2023

Similar companies

Comparable business profile · signals at a glance